Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-04

AUTHORS

Suzanne McMullen, Lisa M. Hess, Edward S. Kim, Benjamin Levy, Mohamed Mohamed, David Waterhouse, Antoinette Wozniak, Sarah Goring, Kerstin Müller, Catherine Muehlenbein, Himani Aggarwal, Yajun Zhu, Ana B. Oton, Jennifer L. Ersek, Katherine B. Winfree

ABSTRACT

INTRODUCTION: Advanced non-small cell lung cancer (NSCLC) is a severe disease with burdensome symptoms and traditionally poor outcomes. The treatment of advance disease is based on chemotherapy, with the recent addition of immunotherapy. Patients who respond to initial treatment can opt to receive maintenance therapy (MT). It is important to understand why patients with advanced NSCLC choose to accept or refuse therapy, and how physician recommendations play into this decision-making process. This study characterized patient and physician decision-making regarding treatment for patients with advanced non-squamous NSCLC in the USA using the example of MT. METHODS AND MATERIALS: This study employed multiple approaches: patient interviews, a patient survey, and a physician survey. Qualitative interviews were conducted among patients who had been offered MT to identify factors influencing treatment decision-making. The patient survey explored the decision-making process and quantified challenges and motivators for receiving MT. The physician survey included a discrete choice experiment to understand the relationship between physician treatment recommendations and patient characteristics. RESULTS: Interviewed patients (n = 10) were motivated to receive MT in the hope of extending their lives and being proactive against their cancer, and they anticipated reduced adverse effects compared with first-line therapy. Surveyed patients (n = 77) described several deterrents to receiving therapy; the most prominent was severity of adverse effects, which was an influencing factor for 34% of patients. The major motivator for receiving therapy was the potential to extend life, which influenced 97% of patients. A total of 100 oncologists participated in the physician survey. Patients' lack of treatment motivation/inconvenience, disease progression, presence of severe renal co-morbidities, and older age decreased the likelihood of physicians recommending the use of MT. CONCLUSION: This study identified challenges and motivators influencing advanced NSCLC patients' decisions to accept or refuse therapy, as well as patient and disease characteristics associated with physician's treatment recommendations for MT. More... »

PAGES

223-233

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3

DOI

http://dx.doi.org/10.1007/s40271-018-0327-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106255770

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30128728


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "ICON Plc, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McMullen", 
        "givenName": "Suzanne", 
        "id": "sg:person.011426620154.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011426620154.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hess", 
        "givenName": "Lisa M.", 
        "id": "sg:person.01006106475.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006106475.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Levine Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.468189.a", 
          "name": [
            "Levine Cancer Institute, Atrium Health, Charlotte, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Edward S.", 
        "id": "sg:person.014001775337.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014001775337.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mount Sinai Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416167.3", 
          "name": [
            "Mount Sinai Health Systems, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levy", 
        "givenName": "Benjamin", 
        "id": "sg:person.01076771225.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076771225.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cone Health", 
          "id": "https://www.grid.ac/institutes/grid.416125.5", 
          "name": [
            "Cone Health, Greensboro, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mohamed", 
        "givenName": "Mohamed", 
        "id": "sg:person.012164362407.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012164362407.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncology Hematology Care", 
          "id": "https://www.grid.ac/institutes/grid.492834.0", 
          "name": [
            "Oncology Hematology Care (OHC), Cincinnati, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Waterhouse", 
        "givenName": "David", 
        "id": "sg:person.01317373531.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317373531.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wayne State University", 
          "id": "https://www.grid.ac/institutes/grid.254444.7", 
          "name": [
            "Karmanos Cancer Institute, Detroit, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wozniak", 
        "givenName": "Antoinette", 
        "id": "sg:person.010560436717.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010560436717.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ICON Plc, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goring", 
        "givenName": "Sarah", 
        "id": "sg:person.015274701305.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015274701305.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ICON Plc, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "M\u00fcller", 
        "givenName": "Kerstin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Muehlenbein", 
        "givenName": "Catherine", 
        "id": "sg:person.0605751225.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605751225.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aggarwal", 
        "givenName": "Himani", 
        "id": "sg:person.010370103253.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010370103253.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Yajun", 
        "id": "sg:person.01347757475.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347757475.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oton", 
        "givenName": "Ana B.", 
        "id": "sg:person.01177655333.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177655333.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Levine Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.468189.a", 
          "name": [
            "Levine Cancer Institute, Atrium Health, Charlotte, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ersek", 
        "givenName": "Jennifer L.", 
        "id": "sg:person.01017444367.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017444367.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Eli Lilly (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417540.3", 
          "name": [
            "Eli Lilly and Company, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Winfree", 
        "givenName": "Katherine B.", 
        "id": "sg:person.01050057502.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050057502.62"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.13-s1-28", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003695569"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(11)70339-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014529972"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2354.2012.01346.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018763292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.19.1114", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020749774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lungcan.2013.03.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026254798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.seminoncol.2013.12.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031003699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ageing/afn226", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035714657"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3747/co.19.1068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040602317"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.47.1102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041282863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0b013e3181fff142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050770715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0738-3991(01)00155-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052263210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0000000000000207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053640246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0025-6196(11)60735-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054591557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ppa.s138863", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091926310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-018-3986-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100404015", 
          "https://doi.org/10.1186/s12885-018-3986-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "INTRODUCTION: Advanced non-small cell lung cancer (NSCLC) is a severe disease with burdensome symptoms and traditionally poor outcomes. The treatment of advance disease is based on chemotherapy, with the recent addition of immunotherapy. Patients who respond to initial treatment can opt to receive maintenance therapy (MT). It is important to understand why patients with advanced NSCLC choose to accept or refuse therapy, and how physician recommendations play into this decision-making process. This study characterized patient and physician decision-making regarding treatment for patients with advanced non-squamous NSCLC in the USA using the example of MT.\nMETHODS AND MATERIALS: This study employed multiple approaches: patient interviews, a patient survey, and a physician survey. Qualitative interviews were conducted among patients who had been offered MT to identify factors influencing treatment decision-making. The patient survey explored the decision-making process and quantified challenges and motivators for receiving MT. The physician survey included a discrete choice experiment to understand the relationship between physician treatment recommendations and patient characteristics.\nRESULTS: Interviewed patients (n\u2009=\u200910) were motivated to receive MT in the hope of extending their lives and being proactive against their cancer, and they anticipated reduced adverse effects compared with first-line therapy. Surveyed patients (n\u2009=\u200977) described several deterrents to receiving therapy; the most prominent was severity of adverse effects, which was an influencing factor for 34% of patients. The major motivator for receiving therapy was the potential to extend life, which influenced 97% of patients. A total of 100 oncologists participated in the physician survey. Patients' lack of treatment motivation/inconvenience, disease progression, presence of severe renal co-morbidities, and older age decreased the likelihood of physicians recommending the use of MT.\nCONCLUSION: This study identified challenges and motivators influencing advanced NSCLC patients' decisions to accept or refuse therapy, as well as patient and disease characteristics associated with physician's treatment recommendations for MT.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s40271-018-0327-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1038760", 
        "issn": [
          "1178-1653", 
          "1178-1661"
        ], 
        "name": "The Patient - Patient-Centered Outcomes Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy", 
    "pagination": "223-233", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6fd0d679787b21e77840c4883428a017c985b4d85e79f8c6f87bbb540ed2186a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30128728"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101309314"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40271-018-0327-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106255770"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40271-018-0327-3", 
      "https://app.dimensions.ai/details/publication/pub.1106255770"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78953_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs40271-018-0327-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40271-018-0327-3'


 

This table displays all metadata directly associated to this object as RDF triples.

233 TRIPLES      21 PREDICATES      44 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40271-018-0327-3 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N370e6f63a7e44daca49e716aab8620cf
4 schema:citation sg:pub.10.1186/s12885-018-3986-5
5 https://doi.org/10.1016/j.lungcan.2013.03.008
6 https://doi.org/10.1016/s0025-6196(11)60735-0
7 https://doi.org/10.1016/s0738-3991(01)00155-0
8 https://doi.org/10.1016/s1470-2045(11)70339-4
9 https://doi.org/10.1053/j.seminoncol.2013.12.013
10 https://doi.org/10.1093/ageing/afn226
11 https://doi.org/10.1097/jto.0000000000000207
12 https://doi.org/10.1097/jto.0b013e3181fff142
13 https://doi.org/10.1111/j.1365-2354.2012.01346.x
14 https://doi.org/10.1200/jco.2012.47.1102
15 https://doi.org/10.1634/theoncologist.13-s1-28
16 https://doi.org/10.2147/ppa.s138863
17 https://doi.org/10.3747/co.19.1068
18 https://doi.org/10.3747/co.19.1114
19 schema:datePublished 2019-04
20 schema:datePublishedReg 2019-04-01
21 schema:description INTRODUCTION: Advanced non-small cell lung cancer (NSCLC) is a severe disease with burdensome symptoms and traditionally poor outcomes. The treatment of advance disease is based on chemotherapy, with the recent addition of immunotherapy. Patients who respond to initial treatment can opt to receive maintenance therapy (MT). It is important to understand why patients with advanced NSCLC choose to accept or refuse therapy, and how physician recommendations play into this decision-making process. This study characterized patient and physician decision-making regarding treatment for patients with advanced non-squamous NSCLC in the USA using the example of MT. METHODS AND MATERIALS: This study employed multiple approaches: patient interviews, a patient survey, and a physician survey. Qualitative interviews were conducted among patients who had been offered MT to identify factors influencing treatment decision-making. The patient survey explored the decision-making process and quantified challenges and motivators for receiving MT. The physician survey included a discrete choice experiment to understand the relationship between physician treatment recommendations and patient characteristics. RESULTS: Interviewed patients (n = 10) were motivated to receive MT in the hope of extending their lives and being proactive against their cancer, and they anticipated reduced adverse effects compared with first-line therapy. Surveyed patients (n = 77) described several deterrents to receiving therapy; the most prominent was severity of adverse effects, which was an influencing factor for 34% of patients. The major motivator for receiving therapy was the potential to extend life, which influenced 97% of patients. A total of 100 oncologists participated in the physician survey. Patients' lack of treatment motivation/inconvenience, disease progression, presence of severe renal co-morbidities, and older age decreased the likelihood of physicians recommending the use of MT. CONCLUSION: This study identified challenges and motivators influencing advanced NSCLC patients' decisions to accept or refuse therapy, as well as patient and disease characteristics associated with physician's treatment recommendations for MT.
22 schema:genre research_article
23 schema:inLanguage en
24 schema:isAccessibleForFree true
25 schema:isPartOf N48077d57d9874be1a93eadf3340c3632
26 Na4ceccdbb201410ebcb0fc187018fccd
27 sg:journal.1038760
28 schema:name Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
29 schema:pagination 223-233
30 schema:productId N35a41b82c8b34eafb5d2ea10be15bcc7
31 N389b3c9b5b8747a4a1cd3460c4ee9841
32 N53ebbdef0833413694922a24a64c7215
33 N7006bd94fd554e41a7bd9a878c98bdf2
34 Nf523cf937afb4e7fb81b579914407b37
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106255770
36 https://doi.org/10.1007/s40271-018-0327-3
37 schema:sdDatePublished 2019-04-11T13:19
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N790fbd0ed9fa40e6ac660eb5f52523f0
40 schema:url https://link.springer.com/10.1007%2Fs40271-018-0327-3
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N04d434711caf48feb27ab1db368352ec schema:name ICON Plc, Vancouver, BC, Canada
45 rdf:type schema:Organization
46 N1beca7b2baf340a0accd30d43d4a3260 rdf:first N3c74e061c5e14cdbb92c3638a7081610
47 rdf:rest N2ece0a716a52434bb275e43a4d88ed21
48 N25a831b3a3c940b68b62c20c9420fc21 rdf:first sg:person.01006106475.67
49 rdf:rest Na9a35f7d6df94656bd074cfc74d44080
50 N2ece0a716a52434bb275e43a4d88ed21 rdf:first sg:person.0605751225.25
51 rdf:rest N86a865b4956d4bbdbd909d2331827d7f
52 N35a41b82c8b34eafb5d2ea10be15bcc7 schema:name dimensions_id
53 schema:value pub.1106255770
54 rdf:type schema:PropertyValue
55 N370e6f63a7e44daca49e716aab8620cf rdf:first sg:person.011426620154.88
56 rdf:rest N25a831b3a3c940b68b62c20c9420fc21
57 N389b3c9b5b8747a4a1cd3460c4ee9841 schema:name doi
58 schema:value 10.1007/s40271-018-0327-3
59 rdf:type schema:PropertyValue
60 N3c74e061c5e14cdbb92c3638a7081610 schema:affiliation Nad59be4c7a5c45c095a16c8b8dc2eac0
61 schema:familyName Müller
62 schema:givenName Kerstin
63 rdf:type schema:Person
64 N40db705e80764651b371acc693814ccb rdf:first sg:person.010560436717.26
65 rdf:rest Naecdc4276f0542d38e6b76db3ba35376
66 N45eaf14921ce4d218cd6d3d126216194 schema:name ICON Plc, Vancouver, BC, Canada
67 rdf:type schema:Organization
68 N48077d57d9874be1a93eadf3340c3632 schema:issueNumber 2
69 rdf:type schema:PublicationIssue
70 N528ba4408e3042eca2d16e9feef43ebe rdf:first sg:person.01317373531.42
71 rdf:rest N40db705e80764651b371acc693814ccb
72 N53ebbdef0833413694922a24a64c7215 schema:name readcube_id
73 schema:value 6fd0d679787b21e77840c4883428a017c985b4d85e79f8c6f87bbb540ed2186a
74 rdf:type schema:PropertyValue
75 N7006bd94fd554e41a7bd9a878c98bdf2 schema:name pubmed_id
76 schema:value 30128728
77 rdf:type schema:PropertyValue
78 N790fbd0ed9fa40e6ac660eb5f52523f0 schema:name Springer Nature - SN SciGraph project
79 rdf:type schema:Organization
80 N7c336e017a8f4d2f99ca1d79192aaba4 rdf:first sg:person.01076771225.72
81 rdf:rest N8c968cde8685420ba912273e7bab7747
82 N86a865b4956d4bbdbd909d2331827d7f rdf:first sg:person.010370103253.14
83 rdf:rest Nd224bdeedba44e5aa6093eedc3c9ca51
84 N8c968cde8685420ba912273e7bab7747 rdf:first sg:person.012164362407.11
85 rdf:rest N528ba4408e3042eca2d16e9feef43ebe
86 N8f05717dbfac4551aeff474e3c4133c3 rdf:first sg:person.01177655333.39
87 rdf:rest N9eda6d306f744bfeb8e63d80289b90f1
88 N9eda6d306f744bfeb8e63d80289b90f1 rdf:first sg:person.01017444367.34
89 rdf:rest Nab6543456cfa48f69cf3247a06f37919
90 Na4ceccdbb201410ebcb0fc187018fccd schema:volumeNumber 12
91 rdf:type schema:PublicationVolume
92 Na9a35f7d6df94656bd074cfc74d44080 rdf:first sg:person.014001775337.24
93 rdf:rest N7c336e017a8f4d2f99ca1d79192aaba4
94 Nab6543456cfa48f69cf3247a06f37919 rdf:first sg:person.01050057502.62
95 rdf:rest rdf:nil
96 Nad59be4c7a5c45c095a16c8b8dc2eac0 schema:name ICON Plc, Vancouver, BC, Canada
97 rdf:type schema:Organization
98 Naecdc4276f0542d38e6b76db3ba35376 rdf:first sg:person.015274701305.67
99 rdf:rest N1beca7b2baf340a0accd30d43d4a3260
100 Nd224bdeedba44e5aa6093eedc3c9ca51 rdf:first sg:person.01347757475.25
101 rdf:rest N8f05717dbfac4551aeff474e3c4133c3
102 Nf523cf937afb4e7fb81b579914407b37 schema:name nlm_unique_id
103 schema:value 101309314
104 rdf:type schema:PropertyValue
105 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical and Health Sciences
107 rdf:type schema:DefinedTerm
108 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
109 schema:name Oncology and Carcinogenesis
110 rdf:type schema:DefinedTerm
111 sg:journal.1038760 schema:issn 1178-1653
112 1178-1661
113 schema:name The Patient - Patient-Centered Outcomes Research
114 rdf:type schema:Periodical
115 sg:person.01006106475.67 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
116 schema:familyName Hess
117 schema:givenName Lisa M.
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006106475.67
119 rdf:type schema:Person
120 sg:person.01017444367.34 schema:affiliation https://www.grid.ac/institutes/grid.468189.a
121 schema:familyName Ersek
122 schema:givenName Jennifer L.
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017444367.34
124 rdf:type schema:Person
125 sg:person.010370103253.14 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
126 schema:familyName Aggarwal
127 schema:givenName Himani
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010370103253.14
129 rdf:type schema:Person
130 sg:person.01050057502.62 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
131 schema:familyName Winfree
132 schema:givenName Katherine B.
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050057502.62
134 rdf:type schema:Person
135 sg:person.010560436717.26 schema:affiliation https://www.grid.ac/institutes/grid.254444.7
136 schema:familyName Wozniak
137 schema:givenName Antoinette
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010560436717.26
139 rdf:type schema:Person
140 sg:person.01076771225.72 schema:affiliation https://www.grid.ac/institutes/grid.416167.3
141 schema:familyName Levy
142 schema:givenName Benjamin
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076771225.72
144 rdf:type schema:Person
145 sg:person.011426620154.88 schema:affiliation N04d434711caf48feb27ab1db368352ec
146 schema:familyName McMullen
147 schema:givenName Suzanne
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011426620154.88
149 rdf:type schema:Person
150 sg:person.01177655333.39 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
151 schema:familyName Oton
152 schema:givenName Ana B.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177655333.39
154 rdf:type schema:Person
155 sg:person.012164362407.11 schema:affiliation https://www.grid.ac/institutes/grid.416125.5
156 schema:familyName Mohamed
157 schema:givenName Mohamed
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012164362407.11
159 rdf:type schema:Person
160 sg:person.01317373531.42 schema:affiliation https://www.grid.ac/institutes/grid.492834.0
161 schema:familyName Waterhouse
162 schema:givenName David
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317373531.42
164 rdf:type schema:Person
165 sg:person.01347757475.25 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
166 schema:familyName Zhu
167 schema:givenName Yajun
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347757475.25
169 rdf:type schema:Person
170 sg:person.014001775337.24 schema:affiliation https://www.grid.ac/institutes/grid.468189.a
171 schema:familyName Kim
172 schema:givenName Edward S.
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014001775337.24
174 rdf:type schema:Person
175 sg:person.015274701305.67 schema:affiliation N45eaf14921ce4d218cd6d3d126216194
176 schema:familyName Goring
177 schema:givenName Sarah
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015274701305.67
179 rdf:type schema:Person
180 sg:person.0605751225.25 schema:affiliation https://www.grid.ac/institutes/grid.417540.3
181 schema:familyName Muehlenbein
182 schema:givenName Catherine
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605751225.25
184 rdf:type schema:Person
185 sg:pub.10.1186/s12885-018-3986-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100404015
186 https://doi.org/10.1186/s12885-018-3986-5
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.lungcan.2013.03.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026254798
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/s0025-6196(11)60735-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054591557
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/s0738-3991(01)00155-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052263210
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/s1470-2045(11)70339-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014529972
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1053/j.seminoncol.2013.12.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031003699
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1093/ageing/afn226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035714657
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1097/jto.0000000000000207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053640246
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1097/jto.0b013e3181fff142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050770715
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1111/j.1365-2354.2012.01346.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018763292
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1200/jco.2012.47.1102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041282863
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1634/theoncologist.13-s1-28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003695569
209 rdf:type schema:CreativeWork
210 https://doi.org/10.2147/ppa.s138863 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091926310
211 rdf:type schema:CreativeWork
212 https://doi.org/10.3747/co.19.1068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040602317
213 rdf:type schema:CreativeWork
214 https://doi.org/10.3747/co.19.1114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020749774
215 rdf:type schema:CreativeWork
216 https://www.grid.ac/institutes/grid.254444.7 schema:alternateName Wayne State University
217 schema:name Karmanos Cancer Institute, Detroit, MI, USA
218 rdf:type schema:Organization
219 https://www.grid.ac/institutes/grid.416125.5 schema:alternateName Cone Health
220 schema:name Cone Health, Greensboro, NC, USA
221 rdf:type schema:Organization
222 https://www.grid.ac/institutes/grid.416167.3 schema:alternateName Mount Sinai Hospital
223 schema:name Mount Sinai Health Systems, New York, NY, USA
224 rdf:type schema:Organization
225 https://www.grid.ac/institutes/grid.417540.3 schema:alternateName Eli Lilly (United States)
226 schema:name Eli Lilly and Company, Indianapolis, IN, USA
227 rdf:type schema:Organization
228 https://www.grid.ac/institutes/grid.468189.a schema:alternateName Levine Cancer Institute
229 schema:name Levine Cancer Institute, Atrium Health, Charlotte, NC, USA
230 rdf:type schema:Organization
231 https://www.grid.ac/institutes/grid.492834.0 schema:alternateName Oncology Hematology Care
232 schema:name Oncology Hematology Care (OHC), Cincinnati, OH, USA
233 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...